Physician profile
Michael J Caron
NPI 1275738023
$882.98
in general payments reported to CMS, 2019-2025
8 companies · $69.79 in 2025
The $69.79 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $184 · 2020: $85.96 · 2021: $165 · 2023: $179 · 2024: $199 · 2025: $69.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $448.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $448.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $220.12 | 2020-2024 | Duraseal Exact Spinal Sealant System, Codman Hakim, Codman Certas |
| Medtronic, INC. | $175.65 | 2021-2025 | Stealthstation S8 Platform, Atlantis Anterior Cervical Plate System, Powerease Instruments |
| Boston Scientific Corporation | $165.41 | 2019-2024 | |
| Stryker Corporation | $151.99 | 2019-2025 | Adherus Autospray Dural Sealant, Duramatrix |
| Ethicon US, LLC | $108.98 | 2021 | |
| Medtronic USA, INC. | $22.67 | 2020 | |
| Orthofix Medical, INC. | $21.84 | 2019 | |
| Aesculap, INC. | $16.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Caron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.